Under standard review timelines, that places potential FDA approval somewhere around mid to late next year
As the neonatal form of CPT II deficiency is typically fatal, early confirmation of the diagnosis should prompt advance care planning discussions with the parents to support timely, appropriate care and informed decision-making in the best interest of the child
PMID: 21940283
L-Carnitine: Description: Unlock the potential of L-Carnitine, a vital amino acid and natural compound that plays a crucial role in energy metabolism
At this stage, the most responsible way to phrase the issue is: Retatrutide may become part of a more advanced generation of metabolic medications, but muscle preservation still depends on the full treatment plan including protein intake, resistance training, dose management, nutrition quality, sleep, hormones, and medical monitoring